Genetics of Appendix Cancer Study (NCT05734430)

🧪 Interventions in This Study

• Genetic profiling (GENETIC)
• Retrospective tissue procurement (OTHER)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• Vanderbilt-Ingram Cancer Center — Nashville, Tennessee

📞 Contact the Study Coordinator

Phone: (615) 936-8544

Email: gapcancerstudy@vumc.org

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Appendix Cancer

• ICARuS Post-operative Intraperitoneal Chemotherapy (EPIC) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) After Optimal Cytoreductive Surgery (CRS) for Neoplasms of the Appendix, Colon or Rectum With Isolated Peritoneal Metastasis — Miami, Florida
• The Appendix Cancer PMP Research Foundation Natural History Study/Patient Registry — Springfield, Pennsylvania

Explore by condition: All Appendix Cancer clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.